Cargando…

Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity

Weight loss can reduce the increased cardiovascular risk associated with obesity. Pharmacotherapy is a recognized weight loss treatment option; however, cardiovascular safety issues with some previous weight loss drugs raise concerns for newly approved pharmacotherapies. Phentermine is approved for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jordan, Jens, Astrup, Arne, Engeli, Stefan, Narkiewicz, Krzysztof, Day, Wesley W., Finer, Nick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011567/ https://www.ncbi.nlm.nih.gov/pubmed/24621808 http://dx.doi.org/10.1097/HJH.0000000000000145

Ejemplares similares

Phentermine-topiramate: First combination drug for obesity
por: Singh, Jagjit, et al.
Publicado: (2015)

Phentermine and topiramate for the management of obesity: a review
por: Cosentino, Gina, et al.
Publicado: (2011)

Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity
por: Shin, Jin Hee, et al.
Publicado: (2013)

Cardiovascular Safety During and After Use of Phentermine and Topiramate
por: Ritchey, Mary E, et al.
Publicado: (2018)

A Narrative Review: Phentermine and Topiramate for the Treatment of Pediatric Obesity
por: Kim, Anthony, et al.
Publicado: (2023)

Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
por: Allison, David B., et al.
Publicado: (2012)

Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
por: Sweeting, Arianne N, et al.
Publicado: (2014)

Combination of venlafaxine and phentermine/topiramate induced psychosis: A case report
por: Homola, Jaclyn, et al.
Publicado: (2018)

Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
por: Garvey, W. Timothy, et al.
Publicado: (2014)

Formulary Management of 2 New Agents: Lorcaserin and Phentermine/Topiramate for Weight Loss
por: Kelly, Elizabeth M., et al.
Publicado: (2013)

Phentermine–topiramate extended release for the dual treatment of obesity and sleep-related eating disorder: a case report
por: Grunvald, Eduardo, et al.
Publicado: (2022)

Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management
por: Garvey, William Timothy
Publicado: (2013)

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study(1)(2)(3)
por: Garvey, W Timothy, et al.
Publicado: (2012)

The Use of Phentermine for Obesity in Psychiatric Patients With Antipsychotics
por: Kim, Eunju, et al.
Publicado: (2023)

Obesity pillars roundtable: Phentermine – Past, present, and future
por: Bays, Harold Edward, et al.
Publicado: (2022)

4-Year Cost Trajectories in Real-World Patients Matched to the Metabolic Profiles of Trial Subjects Before/After Treatment with Phentermine-Topiramate
por: Li, James, et al.
Publicado: (2015)

Case report of PLXNA4 variant associated with hyper-response to phentermine/topiramate pharmacotherapy: Potential genetic basis for superior weight loss response?
por: Paszkowiak, Maria, et al.
Publicado: (2023)

Takotsubo Cardiomyopathy Due to Combined Use of Phentermine and Lisdexamfetamine
por: Burleigh, Tara, et al.
Publicado: (2020)

Postmarketing Surveillance Study of the Efficacy and Safety of Phentermine in Patients with Obesity
por: Kim, Hyun Ok, et al.
Publicado: (2013)

Phentermine, Sibutramine and Affective Disorders
por: An, Hoyoung, et al.
Publicado: (2013)

Effects of anti-obesity drugs, phentermine and mahuang, on the behavioral patterns in Sprague-Dawley rat model
por: Go, Ryeo-Eun, et al.
Publicado: (2014)

Lorcaserin and phentermine exert anti-obesity effects with modulation of the gut microbiota
por: Song, Eun-Ji, et al.
Publicado: (2023)

Effects of Orlistat/Phentermine versus Phentermine on Vascular Endothelial Cell Function in Obese and Overweight Adults: A Randomized, Double-Blinded, Placebo-Controlled Trial
por: Kwon, Yu-Jin, et al.
Publicado: (2021)

Pulmonary Hypertension Associated with Use of Phentermine
por: Bang, Woo-Dae, et al.
Publicado: (2010)

A case of phentermine-induced psychosis: the need for caution for drug-drug interactions
por: Sreevalsam Anil, S., et al.
Publicado: (2023)

Three- and six-month efficacy and safety of phentermine in a Mexican obese population
por: Márquez-Cruz, Maribel, et al.
Publicado: (2021)

RE: Pulmonary Hypertension Associated with Use of Phentermine?
por: Hendricks, Ed J., et al.
Publicado: (2011)

Effects on Weight Reduction and Safety of Short-Term Phentermine Administration in Korean Obese People
por: Kim, Kyoung Kon, et al.
Publicado: (2006)

Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release
por: Guo, Fangjian, et al.
Publicado: (2017)

A Rare Case of Phentermine-Induced Nonischemic Cardiomyopathy
por: Damani, Devanshi, et al.
Publicado: (2022)

Abstract: Phentermine: A Systematic Review for Plastic & Reconstructive Surgeons
por: Lim, Soobin, et al.
Publicado: (2018)

Effects of topiramate, bupropion and naltrexone isolated or combined on subcutaneous adipose tissue in obese rats
por: Scudeler, Monica Alhadas, et al.
Publicado: (2022)

The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases
por: Strauss, Martin H., et al.
Publicado: (2021)

Formulation and evaluation of transdermal drug delivery of topiramate
por: Cherukuri, Suneetha, et al.
Publicado: (2017)

Levetiracetam/topiramate: Drug ineffective: case report
Publicado: (2022)

Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel
por: Hansen, Cerine C., et al.
Publicado: (2018)

MON-095 Phentermine Induces Weight Loss in Prader-Willi Syndrome
por: Mottalib, Adham, et al.
Publicado: (2019)

Phentermine Use During First and Second Trimesters Associated with Fetal Stroke
por: D'Adesky, Nathan, et al.
Publicado: (2019)

Phentermine-Associated Atrial Fibrillation: A Case Report and Literature Review
por: Manasrah, Nouraldeen, et al.
Publicado: (2022)

Effect of Phentermine on Hepatic Steatosis in Bariatric Surgery: A Pilot Study
por: Pérez-Cruz, Elizabeth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_33m6s24tqjkloutqla16jvqdnm